情報源 > 更に詳しい情報[025]
参考文献

(1) Azizi, F. (1996) Effect of methimazole treatment of maternal thyrotoxicosis on thyroid function in breast-feeding infants. Journal of Pediatrics, 128, 855-858.
(2) Bode, H.H., Vanjonack, W.J. & Crawford, J.D. (1978) Mitigation of cretinism by breast-feeding. Pediatrics, 62, 13-brl6.
(3) Cooper, D.S., Bode, H.H., Nath, B., Saxe, V., Maloof, F. & Ridgway, E.C. (1984) Methimazole pharmacology in man: studies using a newly developed radioimmunoassay for methimazole. Journal of Clinical Endocrinology and Metabolism, 58, 473-479.
(4) Cooper, D.S., Saxe, V.C., Meskell, M., Maloof, F. & Ridgway, E.C. (1982) Acute effects of propylthiouracil (PTU) on thyroidal iodide organification and peripheral iodothyronine deiodination: correlation with serum PTU Ievels measured by radioimmunoassay. Journal of Clinical Endocrinology and Metabolism, 54, 101-107.
(5) Johansen, K., Andersen, A.N., Kampmann, J.P., Hansen, J.M. & Mortensen, H.B. (1982) Excretion of methimazole in human milk. European Journal of Clinical Pharmacology, 23, 339-341.
(6) Kampmann, J.P., Johansen, K., Hansen, J.M. & Helweg, J. (1980) Propylthiouracil in human milk: Revison of Dogma. Lancet, l, 736-738.
(7) Lamberg, B.A., Ikonen, E., Osterlund, K., Teramo, K., Pekonen, F., Peltola, J.V. & Valimaki, M. (1984) Antithyroid treatment of maternal hyperthyroidism during lactation. Clinical Endocrinology, 21, 81-87.
(8) Low, L.C.K., Lang, J. & Alexander, W.D. (1979) Excretion of carbimazole and propylthiouracil in breast milk. Lancet, 2, 1011.
(9) Melander, A., Wahlin, E., Danielson, K. & Hanson, A. (1977) Bioavailability of propylthiouracil: interindividual variation and influence of food intake. Acta Medica Scandinavica, 201, 41-44.
(10) McDougall, R. & Bayer, M.F. (1986) Should a woman taking propylthiouracilMc breast-feed? Clinical Nuclear Medicine, 11, 249-250.
(11) Moller, B., Bj6rkhem, I., Falk, O., Lantto, O. & Larsson, A. (1983) Identification of thyroxine in human breast milk by gas chromatography-mass spectrometry. Journal of Clinical Endocrinology and Metabolism, 56, 30-34.
(12) Momotani, N., Yamashita, R., Yoshimoto, M., Noh, Y.J., Ishikawa, N. & Ito, K. (1989) Recovery from foetal hypothyroidism: evidence for the safety of breast-feeding while taking propylthiouracil. Clinical Endocrinology, 31, 591-595.
(13) Nelson, J.C., Clark, S.J., Borut, D.L. et al. (1993) Age-related changes in serum free thyroxine during childhood and adolescence. Journal of Pediatrics, 123, 899-905.
(14) Okuno, A., Taguchi, T., Inyaku, F., Tomei, R.T. & Carlton, E.I. (1983) Pharmacokinetics of propyl-thiouracil in children and adolescents with Graves disease after a single oral dose. Pediatrics Pharmacology, 3, 43-47.
(15) Rylance, G.W., Wood, C.G., Donnelly, M.C., Alexander, W.D. (1987) Carbimazole & breast-feeding. Lancet, l, 928-929.
(16) Tegler, L., Lindstrdm, B. (1980) Antithyroid drugs in milk. Lancet, 2, 591.
(17) Varma, S.K., Collins, M., Row, A., Haller, W.S. & Varma, K. (1978) Thyroxine, tri-iodothyronine, and reverse tri-iodothyronine concentrations in human milk. Journal of Pediatrics, 93, 803-806.

もどる